Director, UTAH Cardiac Transplant Program
Cardiology
Dr. Abdallah G. Kfoury, MD
|
|
Give Review
Abdallah G. Kfoury works in the field of Cardiology. He received awards:"Researcher of the Year", "Best Doctors in America, Cardiovascular Diseases", "Fellow", "Fellow (FACC)" and "Dean's Honor List". Abdallah Kfoury is also published. He has 76 publications published. The lastest publication: "ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.' Abdallah Kfoury is registered with Medicare and accepts Medicare payments.
Publications
- Reasons for, and Outcomes of Patients who were Referred for a Ventricular Assist Device but were Declined: The Recent Era Forgotten Ones.
- The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after Heart transplantation i...
- Mixed cellular and antibody-mediated rejection in Heart transplantation: In-depth pathologic and clinical observations.
- Lactic Acidosis After Cardiac Transplantation: Foe or Common Innocent Bystander?
- Marital status and survival in left ventricular assist device patient populations.
- Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects.
- Myocardial atrophy and Chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.
- Characterization of diffuse fibrosis in the failing human Heart via diffusion tensor imaging and quantitative histological validation.
- Utility of gene expression profiling score variability to predict clinical events in Heart transplant recipients.
- Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials.
- Reply to Letter to the Editor: Left ventricular assist devices in Chronic heart failure: more questions than answers?
- The detection and role of circulating antibodies in rejection.
- Everolimus versus mycophenolate mofetil in Heart transplantation: a randomized, multicenter trial.
- Interleukin receptor family member ST2 concentrations in patients following Heart transplantation.
- Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure: Insights into Cardiac Recovery.
- Pulsatility and the Risk of Non-Surgical Bleeding in Patients Supported With the Continuous-Flow Left Ventricular Assist Device HeartMate II.
- Electromagnetic Interference of Automatic Implantable Cardioverter Defibrillator and HeartWare Left Ventricular Assist Device.
- Morbidity and mortality in Heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing th...
- Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
- Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.
- Bridge to recovery: understanding the disconnect between clinical and biological outcomes.
- Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adve...
- Ventricular assist devices: Pharmacological aspects of a mechanical therapy.
- Prioritizing sensitized Heart transplant candidates: A sensitive affair.
- A longitudinal study of the course of asymptomatic antibody-mediated rejection in Heart transplantation.
- The intermountain risk score predicts incremental age-specific long-term survival and life expectancy.
- Impact of high-dose inotropic donor support on early Myocardial necrosis and outcomes in cardiac transplantation.
- Allograft rejection in patients supported with continuous-flow left ventricular assist devices.
- Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with Coronary disease and a normal comparison population.
- Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum Cardiomyopathy.
- Changing outcomes in patients bridged to Heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the In...
- Left ventricular assist device unloading effects on Myocardial structure and function: current status of the field and call for action.
- Would access to device therapies improve transplant outcomes for adults with congenital heart Disease? Analysis of the United Network for Organ Sharing (UNOS).
- Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices.
- Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?
- End-of-life decision making and implementation in recipients of a destination left ventricular assist device.
- Effect of preservation solution choice on antibody-mediated rejection after Heart transplantation.
- Prolonged allograft ischemic time is not associated with higher incidence of antibody-mediated rejection.
- Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human Heart.
- Risk factors predictive of right ventricular Failure after left ventricular assist device implantation.
- Controversies in defining cardiac antibody-mediated rejection: need for updated criteria.
- Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and Heart transplantation.
- Obesity and left ventricular assist device driveline exit site infection.
- Noninvasive predictor of HeartMate XVE pump failure by neural network and waveform analysis.
- A novel non-invasive method to assess Aortic valve opening in HeartMate II left ventricular assist device patients using a modified Karhunen-Loève transfor...
- Effect of ABO-incompatible listing on infant Heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database.
- Utility of virtual crossmatch in sensitized patients awaiting Heart transplantation.
- Cardiovascular mortality among Heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection.
- Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.
- Exceptional mortality prediction by risk scores from common laboratory tests.
- Superior predictive ability for death of a basic metabolic profile risk score.
- Time-dependent changes in B-type natriuretic peptide after Heart transplantation: correlation with allograft rejection and function.
- Outcome of noncardiac surgery in patients with ventricular assist devices.
- Tuberculosis in a solid-organ transplant recipient: modern-day implications.
- A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in Heart transplantation.
- Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.
- Relation of Heart failure hospitalization to exposure to fine particulate air pollution.
- Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
- Incremental survival benefit with adherence to standardized Heart failure core measures: a performance evaluation study of 2958 patients.
- Early screening for antibody-mediated rejection in Heart transplant recipients.
- Validation of the Seattle Heart Failure Model in a community-based Heart failure population and enhancement by adding B-type natriuretic peptide.
- Molecular testing for long-term rejection surveillance in Heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) tr...
- Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
- Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions.
- Effect of reversible Pulmonary hypertension on outcomes after heart transplantation.
- When the failing, end-stage Heart is not end-stage.
- Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.
- Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in Heart failure.
- Percutaneous Coronary interventions with stents in cardiac transplant recipients.
- Tricuspid Valve replacement after cardiac transplantation.
- Effect of mechanical circulatory support on outcomes after Heart transplantation.
- Bridging the resource gap in Heart failure expertise and management: the underacknowledged role of nurse specialists.
- Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.
- Repeated measurement of the intermountain risk score enhances prognostication for mortality.
- ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Choice Plus POS II
- Altius Health Plans
- Assurant Health
- Blue Card PPO
- Blue Cross of Idaho PPO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Humana
- LifeWise
- Medicare MCR
- ODS Health Plan
- Heritage Plus
- Heritage Signature
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Researcher of the Year
- Best Doctors in America, Cardiovascular Diseases
- Fellow
- Fellow (FACC)
- Dean's Honor List
Education
-
University of Utah -
American University of Beirut Faculty of Medicine
Hospital
-
Intermountain Medical Center
Drug Facts
| NPI NUMBER | 1134132681 | |
| NPPES Provider LastName | KFOURY | |
| NPPES Provider FirstName | ABDALLAH | |
| NPPES Provider ZIPCode | 841431005 | |
| NPPES Provider State | UT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 64.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134132681 |
| Last Name Of The Provider | KFOURY |
| First Name Of The Provider | ABDALLAH |
| View All |
Similar Doctors
|
Dr. John D. Day, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah Budge, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey S. Osborn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward C. Miner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph B. Muhlestein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary P. Symkoviak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Armond M. Lapine, MD
This Doctor is OpenDoctor Recommended.
|